Generic Drug Group Defends Suit Challenging Illinois Pricing Law

At least one member of the national generic drug and biosimilar industry group is likely to face enforcement action under an Illinois anti-price gouging law, the organization argued in a filing defending its lawsuit against the state.

Generic and biosimilar maker Sandoz, Inc. plans to increase the price of one of its generic drugs this year—an action that will likely result in a violation of the now-challenged Illinois law, the Association for Accessible Medicines said Sept 20 in its opposition to Illinois Attorney General Kwame Raoul’s (D) motion to dismiss the case.

The threat of enforcement against Sandoz is enough ...